Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 2, 2012, Pages 273-278

  Socała, Katarzyna ^a   Nieoczym, Dorota ^a   Wyska, Elzbieta ^b   Poleszak, Ewa ^c   Wlaź, Piotr ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antidepressants; Bupropion; Forced swim test; Mice; Sildenafil; Venlafaxine

Indexed keywords

AMFEBUTAMONE; SILDENAFIL; VENLAFAXINE;

ACTIMETRY; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG POTENTIATION; FORCED SWIMMING TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIDEPRESSIVE AGENTS; BUPROPION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANOLS; LOCOMOTION; MALE; MICE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SULFONES; SWIMMING;

MUS;

EID: 84866480362     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.08.012     Document Type: Article

References (58)

1. E.L. Abel Physiological effects of alarm chemosignal emitted during the forced swim J Chem Ecol 19 1993 2891 2901
2. K.K. Akula, A. Dhir, and S.K. Kulkarni Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice Eur J Pharmacol 587 2008 129 134
3. C.B. Brink, J.D. Clapton, B.E. Eagar, and B.H. Harvey Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies J Neural Transm 115 2008 117 125
4. N.S. Bryan, K. Bian, and F. Murad Discovery of the nitric oxide signaling pathway and targets for drug development Front Biosci 14 2009 1 18
5. M.J. Burke, and S.H. Preskorn Therapeutic drug monitoring of antidepressants S.H. Preskorn, J.P. Feigher, C.Y. Stanga, R. Ross, Antidepressants: past, present and future 2004 Springer-Verlag Heidelberg 87 117
6. V. Castagne, P. Moser, S. Roux, and R.D. Porsolt Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice Curr Protoc Pharmacol 2007 5.8.1 5.8.11 [Chapter 5:Unit 5.8A]
7. D. Chau, P.V. Rada, R.A. Kosloff, and B.G. Hoebel Cholinergic, M1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine Ann N Y Acad Sci 877 1999 769 774
8. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology (Berl) 121 1995 66 72
9. A. Dhir, and S.K. Kulkarni Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice Prog Neuropsychopharmacol Biol Psychiatry 31 2007 921 925
10. A. Dhir, and S.K. Kulkarni Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor Eur J Pharmacol 568 2007 177 185
11. A. Dhir, and S.K. Kulkarni Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor Fundam Clin Pharmacol 22 2008 387 394
12. S.C. Dilsaver Cholinergic mechanisms in depression Brain Res 396 1986 285 316
13. J.M. Farre, F. Fora, and M.G. Lasheras Specific aspects of erectile dysfunction in psychiatry Int J Impot Res 16 Suppl. 2 2004 46 49
14. M. Fava, A.J. Rush, M.E. Thase, A. Clayton, S.M. Stahl, and J.F. Pradko 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL Prim Care Companion J Clin Psychiatry 7 2005 106 113
15. M. Fava, H.G. Nurnberg, S.N. Seidman, W. Holloway, S. Nicholas, and L.J. Tseng Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial J Clin Psychiatry 67 2006 240 246
16. M.S. Finkel, F. Laghrissi-Thode, B.G. Pollock, and J. Rong Paroxetine is a novel nitric oxide synthase inhibitor Psychopharmacol Bull 32 1996 653 658
17. G.G. Gould, A.V. Altamirano, M.A. Javors, and A. Frazer A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters Biol Psychiatry 59 2006 408 414
18. A.J. Harkin, K.H. Bruce, B. Craft, and I.A. Paul Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test Eur J Pharmacol 372 1999 207 213
19. A. Harkin, T.J. Connor, M.P. Burns, and J.P. Kelly Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test Eur Neuropsychopharmacol 14 2004 274 281
20. B.H. Harvey, I. Duvenhage, F. Viljoen, N. Scheepers, S.F. Malan, and G. Wegener Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues Biochem Pharmacol 80 2010 1580 1591
21. I.L. Heiberg, G. Wegener, and R. Rosenberg Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats Behav Brain Res 134 2002 479 484
22. A.K. Hotchkiss, L.M. Pyter, M.L. Gatien, J.C. Wen, H.A. Milman, and R.J. Nelson Aggressive behavior increases after termination of chronic sildenafil treatment in mice Physiol Behav 83 2005 683 688
23. R. Hyland, E.G. Roe, B.C. Jones, and D.A. Smith Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil Br J Clin Pharmacol 51 2001 239 248
24. S.Y. Inan, I. Yalcin, and F. Aksu Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation Pharmacol Biochem Behav 77 2004 457 464
25. N.K. Jain, C.S. Patil, A. Singh, and S.K. Kulkarni Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway Brain Res 909 2001 170 178
26. D.S. Janowsky, M.K. el Yousef, J.M. Davis, and H.J. Sekerke A cholinergic-adrenergic hypothesis of mania and depression Lancet 2 1972 632 635
27. D.S. Janowsky, M.K. el Yousef, and J.M. Davis Acetylcholine and depression Psychosom Med 36 1974 248 257
28. S.T. Kaehler, N. Singewald, C. Sinner, and A. Philippu Nitric oxide modulates the release of serotonin in the rat hypothalamus Brain Res 835 1999 346 349
29. M. Krass, G. Wegener, E. Vasar, and V. Volke The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis Behav Brain Res 218 2011 57 63
30. M. Kurt, S.S. Bilge, E. Aksoz, O. Kukula, S. Celik, and Y. Kesim Effect of sildenafil on anxiety in the plus-maze test in mice Pol J Pharmacol 56 2004 353 357
31. Y.F. Li, Y.Z. Zhang, Y.Q. Liu, H.L. Wang, J.B. Cao, and T.T. Guan Inhibition of N-methyl-D-aspartate receptor function appears to be one of the common actions for antidepressants J Psychopharmacol 20 2006 629 635
32. I. Lucki, A. Dalvi, and A.J. Mayorga Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice Psychopharmacology (Berl) 155 2001 315 322
33. C. Lugnier Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents Pharmacol Ther 109 2006 366 398
34. M.J. Millan Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application Pharmacol Ther 110 2006 135 370
35. H.A. Milman, and S.B. Arnold Neurologic, psychological, and aggressive disturbances with sildenafil Ann Pharmacother 36 2002 1129 1134
36. D. Nieoczym, K. Socała, and P. Wlaź Lack of effect of sildenafil on cocaine-induced convulsions in mice Pharmacol Rep 61 2009 930 934
37. D. Nieoczym, J.J. Łuszczki, S.J. Czuczwar, and P. Wlaź Effect of sildenafil on the anticonvulsant action of classical and second-generation antiepileptic drugs in maximal electroshock-induced seizures in mice Epilepsia 51 2010 1552 1559
38. D. Nieoczym, K. Socała, C. Rundfeldt, and P. Wlaź Effects of sildenafil on pentylenetetrazol-induced convulsions in mice and amygdala-kindled seizures in rats Pharmacol Rep 62 2010 383 391
39. D. Nieoczym, K. Socała, J.J. Łuszczki, S.J. Czuczwar, and P. Wlaź Influence of sildenafil on the anticonvulsant action of selected antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice J Neural Transm 119 2012 923 931
40. H.G. Nurnberg Managing treatment-emergent sexual dysfunction associated with serotonergic antidepressants: before and after sildenafil J Psychiatr Pract 7 2001 92 108
41. H.G. Nurnberg, A. Gelenberg, T.B. Hargreave, W.M. Harrison, R.L. Siegel, and M.D. Smith Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors Am J Psychiatry 158 2001 1926 1928
42. H.G. Nurnberg, S.N. Seidman, A.J. Gelenberg, M. Fava, R. Rosen, and R. Shabsigh Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression Urology 60 2002 58 66
43. H.G. Nurnberg, P.L. Hensley, A.J. Gelenberg, M. Fava, J. Lauriello, and S. Paine Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial JAMA 289 2003 56 64
44. P. Pacher, and V. Kecskemeti Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Curr Med Chem 11 2004 925 943
45. M.E. Page, M.J. Detke, A. Dalvi, L.G. Kirby, and I. Lucki Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test Psychopharmacology (Berl) 147 1999 162 167
46. B. Petit-Demouliere, F. Chenu, and M. Bourin Forced swimming test in mice: a review of antidepressant activity Psychopharmacology (Berl) 177 2005 245 255
47. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Ther 229 1977 327 336
48. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioural despair in rats and mice: strain differences and the effects of imipramine Eur J Pharmacol 51 1978 291 294
49. K. Riazi, M. Roshanpour, N. Rafiei-Tabatabaei, H. Homayoun, F. Ebrahimi, and A.R. Dehpour The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway Br J Pharmacol 147 2006 935 943
50. C. Rundfeldt, R. Koch, A. Richter, M. Mevissen, U. Gerecke, and W. Löscher Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats Eur J Pharmacol 274 1995 73 81
51. S.N. Seidman, S.P. Roose, M.A. Menza, R. Shabsigh, and R.C. Rosen Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate Am J Psychiatry 158 2001 1623 1630
52. R.D. Shytle, A.A. Silver, R.J. Lukas, M.B. Newman, D.V. Sheehan, and P.R. Sanberg Nicotinic acetylcholine receptors as targets for antidepressants Mol Psychiatry 7 2002 525 535
53. D. Smith, C. Dempster, J. Glanville, N. Freemantle, and I. Anderson Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis Br J Psychiatry 180 2002 396 404
54. K. Socała, D. Nieoczym, E. Wyska, E. Poleszak, and P. Wlaź Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice J Neural Transm 119 2012 645 652
55. E. Spina, V. Santoro, and C. D'Arrigo Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update Clin Ther 30 2008 1206 1227
56. J. Tignol, P.M. Furlan, M. Gomez-Beneyto, R. Opsomer, W. Schreiber, and M. Sweeney Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression Int Clin Psychopharmacol 19 2004 191 199
57. G. Wegener, V. Volke, B.H. Harvey, and R. Rosenberg Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity Brain Res 959 2003 128 134
58. D. Zhang, B. Yuan, M. Qiao, and F. Li HPLC determination and pharmacokinetics of sustained-release bupropion tablets in dogs J Pharm Biomed Anal 33 2003 287 293